Pharmacielo Ltd (PCLO) - Total Liabilities

Latest as of September 2025: CA$23.57 Million CAD ≈ $17.05 Million USD

Based on the latest financial reports, Pharmacielo Ltd (PCLO) has total liabilities worth CA$23.57 Million CAD (≈ $17.05 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Pharmacielo Ltd - Total Liabilities Trend (2016–2024)

This chart illustrates how Pharmacielo Ltd's total liabilities have evolved over time, based on quarterly financial data. See working capital position of Pharmacielo Ltd to evaluate short-term liquidity relative to the company's equity base.

Pharmacielo Ltd Competitors by Total Liabilities

The table below lists competitors of Pharmacielo Ltd ranked by their total liabilities.

Company Country Total Liabilities
Terragen Holdings Ltd
AU:TGH
Australia AU$1.07 Million
MODERN COMMERCE SA ZY-10
F:8F4
Germany €22.85 Million
Mcphersons Ltd
AU:MCP
Australia AU$45.97 Million
Complii Fintech Solutions Ltd
AU:CF1
Australia AU$2.49 Million
Jenn Feng New Energy Co Ltd
TW:1538
Taiwan NT$131.82 Million
eEducation Albert AB
ST:ALBERT
Sweden Skr99.54 Million
Rajshree Sugars & Chemicals Limited
NSE:RAJSREESUG
India Rs4.08 Billion
Eastern International Ltd.
NASDAQ:ELOG
USA $17.79 Million

Liability Composition Analysis (2016–2024)

This chart breaks down Pharmacielo Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Pharmacielo Ltd (PCLO) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.15 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -1.58 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 2.73 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Pharmacielo Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Pharmacielo Ltd (2016–2024)

The table below shows the annual total liabilities of Pharmacielo Ltd from 2016 to 2024.

Year Total Liabilities Change
2024-12-31 CA$25.91 Million
≈ $18.74 Million
+8.10%
2023-12-31 CA$23.97 Million
≈ $17.34 Million
+28.01%
2022-12-31 CA$18.72 Million
≈ $13.54 Million
+12.58%
2021-12-31 CA$16.63 Million
≈ $12.03 Million
-6.45%
2020-12-31 CA$17.78 Million
≈ $12.86 Million
+275.76%
2019-12-31 CA$4.73 Million
≈ $3.42 Million
+20779.39%
2018-12-31 CA$22.66K
≈ $16.39K
+79.19%
2017-12-31 CA$12.64K
≈ $9.15K
-99.23%
2016-12-31 CA$1.65 Million
≈ $1.19 Million
--

About Pharmacielo Ltd

V:PCLO Canada Drug Manufacturers - Specialty & Generic
Market Cap
$12.24 Million
CA$16.92 Million CAD
Market Cap Rank
#26549 Global
#1093 in Canada
Share Price
CA$0.09
Change (1 day)
-14.29%
52-Week Range
CA$0.04 - CA$0.14
All Time High
CA$11.02
About

PharmaCielo Ltd., together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada. The company's products include medicinal-grade dried cannabis flower, cannabis oil extracts, tetrahydrocannabinol and cannabidiol medical cannabis, and other cannabis related products, as well as provides telemedicine software. The company also exports its… Read more